Apr 22, 2026 07:01AM
Apr 22, 2026 07:00AM
Apr 22, 2026 07:00AM
Apr 6, 2026 07:30AM
Apr 6, 2026 07:30AM
Dec 12, 2025 08:45AM
Dec 12, 2025 08:45AM Actinium Pharmaceuticals Presents New Preclinical Data Demonstrating Potent Anti-Tumor Activity of ATNM-400 Across Multiple Breast Cancer Subtypes Including Hormone Receptor-Positive, Triple-Negative,
Nov 3, 2025 08:30AM
Oct 24, 2025 08:30AM
Oct 13, 2025 12:10PM
Oct 13, 2025 08:30AM
Jun 23, 2025 11:31AM
Jun 23, 2025 11:30AM
Apr 28, 2025 08:36AM Actinium Pharma (ATNM) Presents Data Showing ATNM-400 is More Efficacious than Pluvicto and is Highly Efficacious after Pluvicto Resistance in Prostate Cancer Tumor Models
Apr 28, 2025 08:30AM
Mar 26, 2025 08:45AM
Mar 25, 2025 06:00AM
Mar 17, 2025 08:50AM
Mar 17, 2025 08:50AM
Mar 12, 2025 08:00AM
Mar 11, 2025 08:34AM Actinium Pharma (ATNM) Announces Initiation of Actimab-A Triplet Combination Frontline Trial Under NCI CRADA with Venetoclax and Taiho Oncology's Hypomethylating Agent ASTX-727 in Patients with Newly
Mar 11, 2025 08:30AM
Jul 25, 2024 08:45AM
Jul 25, 2024 08:45AM
May 14, 2024 06:38PM
May 7, 2024 08:00AM
Apr 18, 2024 08:08AM
Apr 18, 2024 08:00AM Actinium Highlights Ability of Iomab-B to Overcome High-Risk TP53 Mutation Resulting in Significant Improvement in Overall Survival in Patients with Active Relapsed Refractory AML at the European Bone
Apr 1, 2024 08:00AM
Apr 1, 2024 08:00AM
Mar 26, 2024 07:18AM
Mar 26, 2024 07:18AM
Jan 2, 2024 07:30AM
Dec 8, 2023 08:00AM
Nov 6, 2023 07:30AM Actinium Presents Preclinical Data at SITC Demonstrating Actimab-A's Potential to Restore T Cell Immunity in the Solid Tumor Microenvironment Supporting Immunotherapy Combinations
Nov 2, 2023 09:05AM
Sep 27, 2023 09:05AM
Aug 31, 2023 07:00AM
Aug 21, 2023 07:00AM
Jun 12, 2023 07:00AM
Jun 7, 2023 07:00AM
May 22, 2023 07:00AM Actinium Pharma Announces Six Abstracts Accepted for Oral and Poster Presentation at the SNMMI 2023 Annual Meeting, Demonstrating Actinium's Leadership in Targeted Radiotherapy for Hematologic and Sol
Apr 27, 2023 10:37AM
Apr 27, 2023 10:36AM
Apr 3, 2023 07:00AM
Dec 12, 2022 08:00AM
Oct 31, 2022 06:00AM
Sep 21, 2022 07:30AM

322,978 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All